What´s new in PubMed this week Panda S, Gurusamy KS, Thakar A, Mitra S, Dwivedi R, Chiumenti FA. Treatment outcomes for human papillomavirus negative oropharyngeal cancer: A meta-analysis. Eur J Surg Oncol. 2025 Apr 1;51(8):110005. doi: 10.1016/j.ejso.2025.110005. Epub ahead of print. PMID: 40250267. A meta-analysis coming from the UK. “Forty-seven studies could be included (randomizedContinue reading “H&N Robotic Surgery Update. April 20, 2025”
Tag Archives: cancer
H&N Robotic Surgery Update. March 30, 2025
What´s new in PubMed this week Bastit V, Lequesne J, Leconte A, Deneuve S, Mouawad F, Quak E, Jeanne C, Clarisse B, Thariat J. Effectiveness of bilateral tongue base mucosectomy by transoral robotic surgery or transoral laser microsurgery in combination with tonsillectomy in identifying head and neck primary cancer of unknown primary: a randomized phaseContinue reading “H&N Robotic Surgery Update. March 30, 2025”
H&N Robotic Surgery Update. February 1, 2025
What´s new in PubMed this week Tong JY, Bzhilyanskaya V, Ferris MJ, Molitoris JK, Hatten KM. Adjuvant Proton Radiation Following Transoral Robotic Surgery for HPV-Positive Oropharyngeal Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2025 Jan 31. doi: 10.1002/ohn.1150. Epub ahead of print. PMID: 39887800. Upon reading the abstract, the fist word that came to myContinue reading “H&N Robotic Surgery Update. February 1, 2025”
El impacto psicológico del Cancer de Cabeza y Cuello
A diferencia de otros tipos de Cáncer, el Cáncer de Cabeza y Cuello, no solo impacta en funciones vitales como la respiración, la articulación de la palabra, o la ingesta de alimento, sino que además sucede en un territorio anatómico en el cual los estigmas de la enfermedad (y de los tratamientos) son visibles. PorContinue reading “El impacto psicológico del Cancer de Cabeza y Cuello”
European Head&Neck Society
I have updated my membership with the European Head & Neck Society (EHNS). This international non-profit organization brings together a multidisciplinary community of professionals, researchers, and patient advocates dedicated to advancing the care of individuals with Head&Neck Cancer. The EHNS aims to promote excellence in research, education, prevention, and patient care, fostering collaboration among cliniciansContinue reading “European Head&Neck Society”
The ORATOR randomized trial
We need to talk about the ORATOR trial. ORATOR is (was) the most ambitious randomized prospective study on TransOral Robotic Surgery (TORS) for oropharyngeal cancer ever attempted. If was targeted at the original decision, which is the primary treatment: primary surgery versus primary radiation therapy. That is the usual critical initial decision we need toContinue reading “The ORATOR randomized trial”
World Cancer Research Day 2024. A call also for surgical research.
September 24th, today, is World Cancer Research Day (see the UICC website). This day aims to “raise awareness of the importance of cancer research as a key driver of advances in prevention and therapeutic strategies that increase survival and reduce the global cancer burden.” When we look at news and posts on the topic, itContinue reading “World Cancer Research Day 2024. A call also for surgical research.”
H&N Robotic Surgery Update. September 14, 2024
What´s new in PubMed this week Trakimas DR, Mydlarz WK, Mady LJ, Gourin CG, Koch W, London NR Jr, Quon H, Kiess AP, Seiwert TY, Fakhry C. Lower survival for surgical treatment of HPV-related oropharynx cancer at community cancer centers. J Natl Cancer Inst. 2024 Sep 9:djae220. doi: 10.1093/jnci/djae220. Epub ahead of print. PMID: 39250754.Continue reading “H&N Robotic Surgery Update. September 14, 2024”
27th July. Word Head&Neck Cancer Day.
At the 5th World Congress of the International Federation of Head & Neck Oncologic Societies (IFHNOS), held in New York in 2014, Congress President and Professor of Head & Neck Surgery at Memorial Sloan Kettering Cancer Center, Jatin P. Shah, announced the establishment of Head&Neck Cancer Awareness Week, and did advocate for the 27th ofContinue reading “27th July. Word Head&Neck Cancer Day.”
Cancer de orofaringe y cirugía robótica
Carta abierta Hace ya 20 años que se describió la cirugía robótica transoral tal y como la conocemos hoy. El desarrollo experimental fue rápidamente seguido de los correspondientes ensayos clínicos y en el año 2009 la FDA aprobó el uso transoral del sistema de cirugía robótica da Vinci. La evidencia médica se ha acumulado enContinue reading “Cancer de orofaringe y cirugía robótica”